RBL1 and cancer: We speculate that RBL1 participates in cell cycle regulation downstream of FoxO signaling and thus by pass the inhibition by Sunitinib and Cabozantinib, both of which were shown to mediate cell cycle arrest as the cancer-intrinsic mechanism [33, 34].